Introduction

GLIEMPAFLOZIN MET ER is a dual-action oral antidiabetic therapy designed to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (25mg) and Metformin Hydrochloride (Extended Release) 1000mg, offering a comprehensive approach to blood sugar control by reducing glucose absorption and improving insulin sensitivity.

Key Features and Ingredients

• Active Ingredients:

  • Empagliflozin (25mg): A SGLT2 inhibitor that helps lower blood glucose levels by promoting glucose excretion through urine

  • Metformin Hydrochloride ER (1000mg): A biguanide that reduces glucose production in the liver and enhances insulin sensitivity

• Mechanism of Action:

  • Empagliflozin: Inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion

  • Metformin ER: Decreases hepatic glucose production, improves insulin sensitivity, and delays glucose absorption in the intestines

• Target Conditions: Type 2 diabetes mellitus

• Formulation: Extended Release (ER) for prolonged and steady glucose control

Usage and Dosage

• Recommended Dose: As prescribed by a healthcare provider, typically once daily with food

• Administration: Swallow whole with water, do not crush or chew

• Duration: Long-term use may be required for diabetes management

Benefits of GLIEMPAFLOZIN MET ER

• Effective Blood Sugar Control: Dual action to reduce blood glucose levels

• Promotes Weight Loss: Empagliflozin aids in calorie loss through urinary glucose excretion

• Cardiovascular Benefits: Empagliflozin has been shown to reduce the risk of cardiovascular complications in diabetic patients

• Improves Insulin Sensitivity: Metformin enhances insulin action and reduces insulin resistance

• Lower Risk of Hypoglycemia: Minimal risk compared to insulin or sulfonylureas

Frequently Asked Questions (FAQs)

1. What is GLIEMPAFLOZIN MET ER used for?

It is used for managing type 2 diabetes mellitus by lowering blood sugar levels through dual mechanisms of Empagliflozin and Metformin ER.

2. How does this combination therapy work?

• Empagliflozin increases glucose excretion through urine, reducing blood glucose levels.

• Metformin ER lowers glucose production in the liver and enhances insulin sensitivity.

3. What are the possible side effects?

Common side effects may include urinary tract infections, dehydration, mild gastrointestinal discomfort, nausea, or diarrhea. Serious side effects such as ketoacidosis or lactic acidosis are rare but require immediate medical attention.

4. Who should avoid taking GLIEMPAFLOZIN MET ER?

Patients with severe kidney disease, metabolic acidosis, or a history of lactic acidosis should consult a doctor before use. Not recommended for type 1 diabetes or diabetic ketoacidosis (DKA).

5. Can it be taken with other diabetes medications?

It can be combined with other antidiabetic agents, but dosage adjustments may be necessary. Always consult a healthcare provider before making changes to your medication regimen.

Conclusion

GLIEMPAFLOZIN MET ER is a highly effective combination therapy for managing type 2 diabetes mellitus. By combining Empagliflozin and Metformin ER, it provides superior blood sugar control, cardiovascular benefits, and weight management support. If you are looking for an advanced diabetes treatment, consult your doctor about GLIEMPAFLOZIN MET ER for better glycemic control and overall health improvement.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW